U.S. Rep. Dan Lipinski, D-Western Springs, joined members of bipartisan groups in the House of Representatives and Senate to push for legislation to lower prescription drug prices.
Lipinski and almost four dozen other House members from both parties have been pushing bills like Strengthening Health Care and the Lowering Prescription Drug Costs Act to push for lower-priced generic drugs, according to a news release.
"Millions of Americans are struggling with the high cost of essential prescription drugs," Lipinski said in the release. "As a diabetic, I know firsthand just how quickly prescription drug costs can add up in a year and how often drug companies raise prices."
A recent study by the Kaiser Family Foundation found that in the past year, 24% of Americans didn't fill a prescription due to high cost. The bicameral, bipartisan agreement aims to support drug price transparency, competition and affordability in the market.
The legislation includes some bills Lipinski has co-sponsored. One bill aims to stop a legal loophole drug companies use to avoid providing testing samples to generic manufacturers.
Another requires the Health and Human Services secretary to publicly disclose rebates, discounts and other price concessions given to pharmaceutical benefits managers. A third requires drug manufacturers to justify large price increases and high launch prices for drugs, and requires the HHS secretary to publicly disclose a summary of the justification.